LEADER 02070nam  2200613 a 450 
001 9910778754703321
005 20230315193026.0
010   $a0-309-17405-8
010   $a1-280-18681-X
010   $a9786610186815
010   $a0-309-59183-X
010   $a0-585-02454-5
035   $a(CKB)110986584752292
035   $a(OCoLC)614707484
035   $a(CaPaEBR)ebrary10055122
035   $a(SSID)ssj0000104212
035   $a(PQKBManifestationID)11130400
035   $a(PQKBTitleCode)TC0000104212
035   $a(PQKBWorkID)10078993
035   $a(PQKB)11227034
035   $a(MiAaPQ)EBC3376128
035   $a(Au-PeEL)EBL3376128
035   $a(CaPaEBR)ebr10055122
035   $a(OCoLC)923261364
035   $a(EXLCZ)99110986584752292
100   $a19980528d1998      ua             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aAntimicrobial resistance $eissues and options : workshop report /$fForum on Emerging Infections, Division of Health Sciences Policy, Institute of Medicine ; Polly F. Harrison and Joshua Lederberg, editors
210  1$aWashington, D.C. :$cNational Academy Press,$d1998.
215   $a1 online resource (127 pages) $cillustrations
300   $aBibliographic Level Mode of Issuance: Monograph
311 0 $a0-309-06084-2 
320   $aIncludes bibliographical references.
606   $aDrug resistance in microorganisms
606   $aAntibiotics
606   $aEmerging infectious diseases$xChemotherapy
615  0$aDrug resistance in microorganisms.
615  0$aAntibiotics.
615  0$aEmerging infectious diseases$xChemotherapy.
676   $a616/.01
701   $aHarrison$b Polly F$01528685
701   $aLederberg$b Joshua$095738
712 02$aInstitute of Medicine (U.S.).$bForum on Emerging Infections.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910778754703321
996   $aAntimicrobial resistance$93797548
997   $aUNINA